Ed Arce
Stock Analyst at Westpark Capital
(4.85)
# 375
Out of 4,352 analysts
1074
Total ratings
48.6%
Success rate
22.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $0.816 | +267.65% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Maintained: Buy | $132 | $2.84 | +4,547.89% | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $60 | $7.92 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $75 | $7.38 | n/a | 33 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Maintained: Buy | $7.5 | $1.02 | n/a | 85 | Apr 4, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $4.93 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Maintained: Hold | n/a | $2.52 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $70 | $5.70 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Maintained: Hold | n/a | $27.66 | n/a | 30 | Mar 21, 2025 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $240 | $1.98 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.26 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $7.29 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $405 | $497.27 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $72 | $101.50 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.5 | $6.04 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $23.94 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $13.16 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $4.56 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $22 | $47.18 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $33.68 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.079 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $15.33 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.66985 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $0.205 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $35.52 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7536 | n/a | 39 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.54 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.30 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.80 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $4.29 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $33.61 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.31 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $2.83 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 | $0.001 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $32.74 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.645 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $8.91 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0002 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $41.71 | n/a | 3 | Nov 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.001 | n/a | 2 | Mar 19, 2013 |
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $0.816
Upside: +267.65%
MetaVia
Sep 17, 2025
Maintained: Buy
Price Target: $132
Current: $2.84
Upside: +4,547.89%
Arcturus Therapeutics Holdings
Apr 11, 2025
Maintained: Buy
Price Target: $60
Current: $7.92
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Maintained: Buy
Price Target: $75
Current: $7.38
Upside: n/a
Akebia Therapeutics
Apr 4, 2025
Maintained: Buy
Price Target: $7.5
Current: $1.02
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $4.93
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Maintained: Hold
Price Target: n/a
Current: $2.52
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Maintained: Buy
Price Target: $70
Current: $5.70
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Maintained: Hold
Price Target: n/a
Current: $27.66
Upside: n/a
Acurx Pharmaceuticals
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.98
Upside: n/a
Mar 18, 2025
Maintained: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $32
Current: $7.29
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $400 → $405
Current: $497.27
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $66 → $72
Current: $101.50
Upside: n/a
Feb 20, 2025
Maintained: Hold
Price Target: $5.5
Current: $6.04
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $95
Current: $23.94
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $18
Current: $13.16
Upside: n/a
Jan 21, 2025
Maintained: Buy
Price Target: $5
Current: $4.56
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $47.18
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $48
Current: $33.68
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $5
Current: $0.079
Upside: n/a
Sep 5, 2024
Maintained: Buy
Price Target: $13
Current: $15.33
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.66985
Upside: n/a
Mar 26, 2024
Maintained: Buy
Price Target: $120
Current: $0.205
Upside: n/a
Jan 25, 2024
Maintained: Buy
Price Target: $25
Current: $35.52
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.7536
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Maintained: Hold
Price Target: n/a
Current: $17.54
Upside: n/a
Nov 29, 2021
Maintained: Hold
Price Target: n/a
Current: $0.30
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $8.80
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: €12.00
Current: $4.29
Upside: n/a
Feb 7, 2020
Maintained: Buy
Price Target: $29 → $31
Current: $33.61
Upside: n/a
Nov 11, 2019
Maintained: Hold
Price Target: n/a
Current: $1.31
Upside: n/a
Aug 12, 2019
Maintained: Buy
Price Target: $27
Current: $2.83
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $1.25
Current: $0.001
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $32.74
Upside: n/a
Nov 6, 2017
Maintained: Hold
Price Target: n/a
Current: $0.645
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Jan 26, 2015
Maintained: Buy
Price Target: $20
Current: $8.91
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0002
Upside: n/a
Nov 14, 2014
Reiterated: Buy
Price Target: $9
Current: $41.71
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.001
Upside: n/a